NuVasive Expands its Advanced Materials Science™ Portfolio

VERITAS Vision System Is Introduced by Johnson & Johnson

The company will offer live demos of the new system in a wet lab at the Johnson & Johnson booth (#2813) this weekend at the 2021 American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Annual Meeting.

GenesisCare Orders 27 Elekta Flexitron Treatment Devices

"GenesisCare continues to demonstrate its commitment to improving patient outcomes worldwide and Elekta is delighted to play a vital partnering role to achieve this mission," said Gustaf Salford, Elekta's President and CEO.

FoodMarble AIRE Shown to Exceed the Performance of ‘Gold Standard’ SIBO Testing in Clinical Trial

SIBO is a very common disorder where there are excessive bacteria present in the small intestine. The true prevalence of SIBO in the general population is largely unknown, with some studies estimating its occurrence in up to 15% of healthy individuals. It is also largely associated with many other common clinical conditions, including irritable bowel syndrome, where 40-80% of IBS patients have SIBO.

NuVasive, Inc. announced the commercial launch of Modulus® TLIF-A, a porous titanium spine implant engineered for the transforaminal lumbar interbody fusion (TLIF) procedure. This offering completes the Company’s Advanced Materials Science™ (AMS) portfolio for all major posterior interbody fusion techniques used in TLIF, the most commonly performed procedure in the spine industry.

The availability of Modulus TLIF-A further extends NuVasive’s technology offerings in the spinal deformity market given its differentiated ability to provide anterior column support, increase segmental lordosis and maximize capability to restore sagittal alignment. This solution increases the Company’s footprint in the U.S. interbody device market, which is estimated to be more than $1.2 billion, and extends its entire AMS portfolio to a global patient audience with significant market share in anteriorly placed TLIF implants.1 Furthermore, the system is designed to work seamlessly with the Company’s MAS® TLIF and MAS Midline access systems allowing customization options to specific surgical techniques.

“The Modulus TLIF-A system is the perfect synergy between optimized material properties and deliverability,” said Jeffrey L. Gum, MD, orthopedic surgeon at the Norton Leatherman Spine Center. “The lattice design allows for improved imaging characteristics, a prime environment to promote fusion and an ideal modulus of elasticity. Additionally, the system optimizes surgical workflow by utilizing a single instrument for implant insertion and articulation.”

Modulus TLIF-A is an anteriorly placed implant featuring a porous titanium surface technology that is designed to promote bone in-growth and bone on-growth. Animal studies also demonstrated stronger osseointegration than solid implants with smooth or rough surfaces.2-5 This optimized lattice structure enables enhanced imaging for visualization of spinal fusion compared to solid titanium interbody implants.

“This complete portfolio offering for the thoracolumbar posterior procedures space is yet another example of NuVasive’s commitment to deliver differentiated technology that supports better patient outcomes,” said Matt Link, president of NuVasive. “NuVasive’s implants are designed to combine the inherent benefits of porosity with the advantageous material properties of PEEK and titanium to create implants intelligently designed for fusion, which we believe out performs traditional and competitive implants in the market.”

In June, the company announced the launch of Modulus TLIF-O, integrating the Modulus technology with an implant designed with a lordosis cut in the oblique plane to maximize sagittal correction without introducing the undesired coronal deformity commonly seen with standard oblique implant offerings. With the availability of Modulus TLIF-A, the company plans to launch its comprehensive Advanced Materials Science TLIF portfolio in the global market later this year.



Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.